Tesaro

^{Priced, Nasdaq: TSRO}

Developing drugs for chemotherapy-induced nausea and solid tumors.

Industry: Health Care

First Day Return: +1.4%

TSRO

Developing drugs for chemotherapy-induced nausea and solid tumors.

IPO News for Tesaro

Tesaro prices IPO at $13.50, within the range 06/28/12
5 US IPOs planned for the week of Jun 25 06/25/12
Biotech Tesaro sets terms for $81 million US IPO 06/19/12

IPO Data
IPO Date	06/27/2012
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$81
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.tesarobio.com
Headquarters	Waltham, MA, United States
Founded	2010
Employees at IPO	20

IPO News for Tesaro

Tesaro prices IPO at $13.50, within the range 06/28/12
5 US IPOs planned for the week of Jun 25 06/25/12
Biotech Tesaro sets terms for $81 million US IPO 06/19/12

Tesaro (TSRO) Performance